|
|
|
|
| Advertisement |
 |
|
|
| Advertisement |
A Molecule's Journey - Breaking Down Roadblocks to Commercial Success
In this guidebook, our experts share some key considerations to help biopharmaceutical companies successfully advance a molecule from the laboratory to the clinic as quickly as possible without sacrificing product quality, process efficiency, or patient safety.
 Download the White Paper »
|
|
| Advertisement |
Regulatory Information Management Best Practices
Read this Executive Summary to learn how to reduce regulatory complexity, ensure data quality and improve the user experience while ensuring compliance.
 Download Now
|
|
| Reputation |
 |
|
Engaging Patients, Engaging the Public |
Pharm Exec speaks to Jane Griffiths, Global Head of Actelion, about the current state of the industry's reputation and the work that needs to be done to further build trust with patients and the public
… /Read more/ |
|
|
| Advertisement |
CRO Consolidation: A Sinister Threat or Windfall for Pharma?
Live Webcast: Tuesday, March 27 at 1:00pm EDT
 Register now
|
|
|
|
| Advertisement |
 |
|
|
| Interview |
 |
|
Valeant's Northern Face |
Richard Lajoie, the new head of Valeant Canada, shares his main priorities for the business, including growing its domestic manufacturing as a key cog globally
… /Read more/ |
|
|
| Advertisement |
The Rare Disease Revolution
On Demand
 Learn more
|
|
| Advertisement |
Maximizing Medical Affairs Impact through Strategic Alignment and Collaboration: Best Practice and Live Benchmarking
On Demand
 Learn more
|
|
| Event |
 |
|
Life Sciences GDPR Prep Forum |
With the May 25 deadline fast approaching, life sciences organizations must take the necessary steps to ensure compliance with the new requirements of the General Data Protection Regulation (GDPR). CBI's Life Sciences GDPR Prep Forum (March 12, Philadelphia, PA) is a one-day summit dedicated to helping companies prepare for the regulation
… /Read more/ |
|
|
|
| Industry update |
| // Arcturus Therapeutics Ltd (San Diego, CA) announced that Dr. Christine Esau, Senior Director of Translational Research, has been appointed as Vice President of Research and Development, effective immediately. The company also reported that Pad Chivukula is stepping down as Chief Scientific Officer and Chief Operating Officer and will serve as a Scientific Advisor to the company. // Sunesis Pharmaceuticals (South San Francisco, CA) announced that H. Ward Wolff has been appointed to the Board of Directors. // Maureen Cronin, M.D., Ph.D., formerly Head of Women's Health at Bayer Schering Pharma, joined medtech startup Ava (Zurich, Switzerland, and San Francisco, CA) as Chief Medical Officer. // Poseida Therapeutics (San Diego, CA) announced that Martin Giedlin, Ph.D., joined the company as Vice President, Technical Operations. // Bellicum Pharmaceuticals (Houston, TX) appointed William Grossman, M.D., Ph.D., as Chief Medical Officer. Dr. Grossman joins from Genentech/Roche. // Voyager Therapeutics (Cambridge, MA) announced plans during 2018 for Steven Paul, M.D., to transition from President and CEO to Executive Science Advisor. Dr. Paul will continue to serve on Voyager's Board of Directors, and as a member of the company's Science & Technology Committee. //
|
|
|
